Medicines, Vaccines and Health Technologies

Biodata:

Adriana M. Ivama is the Sub Regional Advisor of Medicines, Vaccines and Health Technologies at Caribbean Programme Coordination Office, appointed in January 2009. She is national from Brazil and a former Health Surveillance and Regulation Specialist of the National Agency of Health Surveillance (Anvisa)/Brazilian Ministry of Health. Her previous experience includes being a researcher and a professor of Public Health at the University of Londrina (Brazil).

She has a PhD in Public Health, Health Legislation and History of Sciences from the University of Alcala (Spain) and specializations in International Health from the University of Sao Paulo (Brazil), Health Surveillance from the Oswaldo Cruz Foundation (Brazil) and Teaching Methodology from the State University of Londrina (Brazil). She initially graduated with the degree in Pharmacy.

Her experience in public health includes pharmaceutical policies and regulation, development of human resources, project management, planning and evaluation.

She has collaborated with CPC Office on the Medicines and Health Technologies Project for the last 2 years and worked in the PWR Brazil.

Area of work:

Main duties are:

1. to implement the European Union/World Health Organization project "Partnership on Pharmaceutical Policies in the Caribbean; aligned with global and regional strategic orientations in medicines, vaccines and health technologies into the PAHO/WHO and Caribbean governing bodies";
2. to promote networks, partnerships, inter-country cooperation and commitment of stakeholders, with support of PAHO/WHO Collaborating Centres and mobilizing experts;
3. to assist the Caribbean Region and CARICOM Secretariat in the development of sub-regional framework on pharmaceutical policy, regulation and indicators assessing implementation and impact on access to medicines and strengthening these issues at national level.
4. to provide technical support to participating countries on issues of access to medicines & vaccines.
5. to strengthening capacity in pharmaceutical supply management, identifying needs based on assessments.